Developing medicines
Responding to COVID-19
Clinical trials and research
Building a thriving environment for medicine discovery
UK-EU Future Relationship
Life Sciences Industrial Strategy
ABPI Medical Representatives Exam
Accessing medicines
How medicines are priced in the UK
Working with the NHS
Supply chain
Antimicrobial resistance (AMR)
Vaccines
What is the NICE Methods Review?
Rare diseases: Facing three challenges
Our ethics
Disclosure UK
Appropriate prescribing
Patient & public involvement
Member representation
Events
Full membership
Working with our members
ABPI Members List
Membership benefits
Who We Are
Media
Publications
Facts and Figures
Contact Us
ABPI Meetings (Adam.ai)
The Association of the British Pharmaceutical Industry
Facts and figures
Clinical trial data
Number of commercial clinical trials started by country, Phase I (2012-2018)
Number of commercial clinical trials started by country, Phase I (2012-2018)
Figure 4. Number of commercial clinical trials started by country, Phase I (2012-2018)
Figure 4. Number of commercial clinical trials started by country, Phase I (2012-2018)
Clinical trial data
Number of commercial clinical trials started in the UK, by year and phase (2012-2018)
Number of commercial clinical trial applications received by MHRA, by year (2013-2018)
Number of clinical trial applications received by MHRA in 2018, by phase and sponsor type
Number of commercial clinical trials started by country, Phase I (2012-2018)
Number of commercial clinical trials started by country, Phase II (2012-2018)
Number of commercial clinical trials started by country, Phase III (2012-2018)
Number of commercial clinical trials started in the UK, by year and disease area (2012-2018)
Number of commercial clinical trials started in oncology, by year and country (2012-2018)
Number of commercial clinical trials started in cardio-metabolic diseases, by year and country (2012-2018)
Number of commercial clinical trials started in nervous system diseases, by year and country (2012-2018)
Number of commercial clinical trials started in immune disorders, by year and country (2012-2018)
Number of commercial clinical trials started in infectious diseases, by year and country (2012-2018)
